REVONA BIO LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Revona Bio Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Revona Bio Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
REVONA BIO LTD is an active private limited company (company number 14236436) incorporated on 15 July 2022, registered in Walsall. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 July 2025, showing net assets of −£616k and cash of £220k, with 8 employees on average. Net assets fell 86% on the prior period (−£332k).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
No active person with significant control is registered.
- Dr Anastasia Jane Callaghan
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Charlotte Anne Henderson
- owns 25–50% of shares
- holds 25–50% of voting rights
- The University Of Portsmouth
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 15 July 20224 yrs ago
- Next accounts due
- 30 April 2027in 187 days
- Confirmation statement due
- 29 July 2027in 277 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | −£616k | £220k | £139k | — | — | — | 8 |
| 30 September 2024 | −£332k | £470k | £151k | — | — | — | 7 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-615,644 at 31 July 2025
- Net assets down 25% or more on the prior period-85.6% vs prior period
- Cash at bank of £50,000 or moreCash £220,325
- Incorporated two to five years agoIncorporated 15 July 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 277 days
- Next accounts duein 187 days
- Accounts period endNet liabilities £616k · small accounts
- Accounts period endNet liabilities £332k · small accounts
- Incorporated
Similar companies in Birmingham
- FP BIOGENIC LTDBirmingham · inc. Sept 2022
- THERAPORT LTDWalsall · inc. May 2022
- ADTHERA BIO LIMITEDBirmingham · inc. Sept 2022
- SICCA THERAPEUTICS LIMITEDRedditch · inc. Mar 2022
- ARDEN BIOTECHNOLOGY LIMITEDTamworth · inc. Feb 2022
- SHAROO LIMITEDBirmingham · inc. Feb 2022
All companies incorporated on 15 July 2022 · in Jul 2022.
Reminders for REVONA BIO LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.